October 07, 2019
Düsseldorf/Vineland, New Jersey, October 07, 2019. Gerresheimer is driving innovation in pharmaceutical glass, primary packaging glass products, technologies...
More July 11, 2019
Revenues up 7.2% on the prior-year quarter to EUR 356.5m Adjusted EBITDA at EUR 74.2m in second quarter of 2019 (Q2 2018: EUR 71.1m), excluding EUR 26.2m from...
More June 06, 2019
Duesseldorf, June 6, 2019 – Payment of a dividend of EUR 1.15 per share was approved at the Annual General Meeting of Gerresheimer AG held today in...
More May 14, 2019
Duesseldorf, May 14, 2019 – Dr. Bernd Metzner (48) takes up the position of Chief Financial Officer of Gerresheimer AG on May 15, 2019. Dr. Metzner had been...
More April 11, 2019
Revenues up 6.3% on the prior-year quarter to EUR 308.5m Adjusted EBITDA at EUR 145.9m in first quarter of 2019 (Q1 2018: EUR 52.6m), comprising of EUR 53.6m...
More March 07, 2019
Duesseldorf/Skopje (North Macedonia), March 7, 2019 – Gerresheimer AG is to build a new plant in Skopje, Republic of North Macedonia. “As part of our growth...
More February 14, 2019
Revenues at constant exchange rates up 4.3% in the financial year 2018 to EUR 1,406.7m Adjusted EBITDA at constant exchange rates at EUR 307.5m, excluding the...
More November 28, 2018
Duesseldorf, November 28, 2018 – Dr. Bernd Metzner (48) is to become Chief Financial Officer of Gerresheimer AG, taking up office at the latest on July 1,...
More October 11, 2018
Revenues at constant exchange rates up 8.8% in third quarter of 2018 to EUR 364.4m Adjusted EBITDA at constant exchange rates—excluding Sensile Medical and...
More October 11, 2018
Duesseldorf, October 11, 2018—Andreas Schütte (56) will step down from the Management Board of Gerresheimer AG at his own request as of February 28, 2019 in...
More 